Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Flexi Cap Fund median (47 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 15 Nov 2023 – 20 Aug 2026, limited by Helios Flexi Cap Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Helios Flexi Cap Fund | Nifty 500 |
|---|---|---|
| 15 Nov 2023 | ₹100.00 | ₹100.00 |
| 07 Feb 2024 | ₹114.29 | ₹114.86 |
| 01 May 2024 | ₹123.78 | ₹119.93 |
| 24 Jul 2024 | ₹133.17 | ₹130.92 |
| 16 Oct 2024 | ₹139.92 | ₹135.21 |
| 08 Jan 2025 | ₹135.91 | ₹126.98 |
| 03 Apr 2025 | ₹127.30 | ₹121.34 |
| 26 Jun 2025 | ₹139.92 | ₹134.32 |
| 18 Sep 2025 | ₹147.46 | ₹134.33 |
| 11 Dec 2025 | ₹145.99 | ₹134.51 |
| 05 Mar 2026 | ₹139.04 | ₹129.64 |
| 28 May 2026 | ₹145.99 | ₹131.18 |
| 20 Aug 2026 | ₹153.23 | ₹134.30 |
| Metric | Helios · Regular · IDCW NAV ₹15.66 Very High risk ★★★☆☆ 1Y | Category median Flexi Cap Fund · 47 funds |
|---|---|---|
| +6.31% | +1.86% | |
| — | +11.07% | |
| — | +8.68% | |
| — | +5.89% | |
| +16.71% | +10.09% | |
| +10.83% | — | |
| — | +13.05% | |
| — | +11.30% | |
| — | +6.14% | |
| Risk | ||
| 16.47% | 14.74% | |
| -0.01 | 0.29 | |
| -0.01 | 0.39 | |
| -18.47% | -33.63% | |
| Nifty 500 | — | |
| +5.33% | -0.84% | |
| 0.99 | 0.98 | |
| 113.1% | 96.3% | |
| 87.0% | 102.5% | |
| 2.07% | 2.15% | |
| ₹6,929Cr | ₹3,777Cr | |
| Up to 1.00% | — | |
| None | — | |
| ₹2.03K | — | |
| ₹5.00K | — | |
| 33% | 37% | |
| Alok Bahl · 0.9y | — | |
| 15 Nov 2023 | — | |
| 68 | — | |
| 31.7% | — | |
| 1.0% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.